This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In the November/December 2015 issue of PharmaVOICE, Rhett Johnson explains that to achieve better value, the health care industry must define what value looks like and measure how effectively it is being produced. To read the article, click here.
Are GLP-1 weight-loss therapies growing primarily by expanding the treatment population or by capturing share from existing obesity therapies? Obesity afflicts...
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...
As the center of life sciences innovation increasingly shifts to China, companies must be ready for a more complex international arbitration landscape. In this...
Daniel Shack is a panelist during the session titled “Survey Says…” In recent proceedings, consumer survey evidence has been tendered. What’s it for? What’s it...
